JLP-1310

DRUG2 trials

Sponsors

Jeil Pharmaceutical Co., Ltd.

Conditions

DiabetesHyperlipidemiaHyperlipidemias

Phase 1

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers

CompletedNCT02982798

Jeil Pharmaceutical Co., Ltd.Diabetes, Hyperlipidemia

Start: 2017-07-06End: 2018-01-31Updated: 2018-03-29

The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers.

CompletedNCT03690778

Jeil Pharmaceutical Co., Ltd.Diabetes, Hyperlipidemias

Start: 2018-10-04End: 2019-02-01Updated: 2019-03-29